Find a Tender
complete
Official procurement procedure
NP35925 Cardiovascular & Respiratory Medicines
Pharmaceutical products
Published value
Not published
Submission deadline Not published
Lots published15
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS): "NP35925 Cardiovascular & Respiratory Medicines". Published status: complete. Published value: Value not published. 15 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Market Analytics
Derived from OCDS awards & bid statistics
Published history for The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
6.9Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 579 active published awards; 550 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published | Procurement categoryNot published | |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published6 May 2025, 11:14 BST | Last source update6 May 2025, 11:14 BST | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area | ||
OCIDocds-h6vhtk-04afa6 | ||
What is being bought
This Framework Agreement is for the supply of Cardiovascular & Respiratory Medicines to health boards across NHS Scotland. The Goods have been split into nineteen (19) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
What changed
From the official release history
- tender value changed
6 May 2025, 11:14 BST - Status changed to complete
6 May 2025, 11:14 BST - Official notice release published
6 May 2025, 11:14 BST - Submission deadline changed to published date
6 May 2025, 11:14 BST - Published value updated to £95,148,458
21 Oct 2024, 14:00 BST - Status changed to active
21 Oct 2024, 14:00 BST - Official notice release published
21 Oct 2024, 14:00 BST - Submission deadline changed to 20 Nov 2024, 12:00 GMT
21 Oct 2024, 14:00 BST - Buyer information updated
21 Oct 2024, 14:00 BST
Lots and requirements (15)
Published by the contracting authority
- Lot 1 · #10Nifedipine Modified-Release (M/R) Capsules and TabletscancelledPublished valueNot publishedSupply of Nifedipine Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #12Branded and Branded Generic InhalerscancelledPublished valueNot publishedSupply of Branded and Branded Generic Inhalers to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 3 · #13Iloprost MedicinescancelledPublished valueNot publishedSupply of Iloprost Solutions for Infusion and Nebuliser solutions to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 4 · #14Dalteparin InjectionscancelledPublished valueNot publishedSupply of Dalteparin Injection to NHS Scotland in a range of presentations. The Authority intends awarding a multi supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded per line. Full details can be found within the ITT.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 5 · #15Tinzaparin Sodium InjectionscancelledPublished valueNot publishedSupply of Tinzaparin Sodium Injection to NHS Scotland in a range of presentations. The Authority intends awarding a multi supplier unranked framework agreement on a lot basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 6 · #16Icatibant Solution for InjectioncancelledPublished valueNot publishedSupply of Icatibant Solution for Injection to NHS Scotland. The Authority intends awarding a multi supplier ranked Framework Agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded per line. Full details can be found within the ITT.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 7 · #17Treprostinil InjectioncancelledPublished valueNot publishedSupply of Treprostinil Injection to NHS Scotland in a range of presentations. The Authority intends awarding an unranked multi supplier framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 8 · #18Direct Acting Oral Anticoagulants (DOACs)cancelledPublished valueNot publishedSupply of Direct Acting Oral Anticoagulants (DOACs) to NHS Scotland in a range of presentations. The Authority intends awarding a multi supplier ranked Framework Agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded per line. Full details can be found within the ITT.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 9 · #19All Other Cardiovascular & Respiratory MedicinescancelledPublished valueNot publishedSupply of All Other Cardiovascular & Respiratory Medicines to NHS Scotland in a range of presentations. Each product line will be treated as an individual Lot. The Authority intends awarding each product line to a single Framework Participant. Full details can be found within the ITT.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 10 · #2Epoprostenol Powder and Solvent (pH 12) for Solution for Infusion VialscancelledPublished valueNot publishedSupply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH12) for solution for infusion vials to NHS Scotland. The Authority intends awarding a multi-supplier unranked framework agreement for the Lot and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 11 · #3Epinephrine (Adrenaline) Pre-Filled SyringescancelledPublished valueNot publishedSupply of Epinephrine (Adrenaline) Pre-filled syringes to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 12 · #5Enoxaparin Sodium InjectioncancelledPublished valueNot publishedSupply of Enoxaparin Sodium Injection to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 13 · #7Isosorbide Mononitrate Modified-Release (M/R) Capsules and TabletscancelledPublished valueNot publishedSupply of Isosorbide Mononitrate Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 14 · #8Diltiazem Hydrochloride Modified-Release (M/R) Capsules and TabletscancelledPublished valueNot publishedSupply of Diltiazem Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 15 · #9Verapamil Hydrochloride Modified-Release (M/R) Capsules and TabletscancelledPublished valueNot publishedSupply of Verapamil Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intends awarding each product line as a multi-supplier unranked framework agreement on a line by line basis and it is envisaged a maximum of 6 Framework Participants will be awarded. Full details can be found within the ITT.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
6 May 2025, 11:14 BST - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 7 Apr 2025, 00:00 BST · £1,575,630 - Contract active
Signed 7 Apr 2025, 00:00 BST · £848,290 - Contract active
Signed 7 Apr 2025, 00:00 BST · £170,315 - Contract active
Signed 7 Apr 2025, 00:00 BST · £223,250 - Contract active
Signed 7 Apr 2025, 00:00 BST · £446,140 - Contract active
Signed 7 Apr 2025, 00:00 BST · £24,410,075 - Contract active
Signed 7 Apr 2025, 00:00 BST · £13,855 - Contract active
Signed 7 Apr 2025, 00:00 BST · £10,789,555 - Contract active
Signed 7 Apr 2025, 00:00 BST · £9,947,020 - Contract active
Signed 7 Apr 2025, 00:00 BST · £53,405 - Contract active
Signed 7 Apr 2025, 00:00 BST · £81,720 - Contract active
Signed 7 Apr 2025, 00:00 BST · £37,695 - Contract active
Signed 7 Apr 2025, 00:00 BST · £2,961,460 - Contract active
Signed 7 Apr 2025, 00:00 BST · £257,595 - Contract active
Signed 7 Apr 2025, 00:00 BST · £30,489,875
Commercial outcome and competition
Awards Aguettant Ltd, Martindale Pharma Not published · Not published · active Northumbria Healthcare NHS Foundation Trust Not published · Not published · active Celix Pharma Ltd., Glenmark Pharmaceuticals Europe Ltd, Hikma Pharmaceutical International Limited, Martindale Pharma, STADA UK - Thornton & Ross, Wockhardt UK Limited Not published · Not published · active Dr Reddy's Laboratories (UK) Ltd Not published · Not published · active Aspire, Celix Pharma Ltd., Glenmark Pharmaceuticals Europe Ltd, MSN Labs, Perennial Pharma Ltd, STADA UK - Thornton & Ross, Sandoz, Viatris UK Healthcare Ltd, Wockhardt UK Limited, Zentiva Pharma UK Ltd Not published · Not published · active Accord, Aguettant Ltd, Aspire, Aventis Pharma Ltd t/a Sanofi, Bowmed Ibisqus Limited, Bristol Laboratories, CST Pharma Ltd, Colonis Pharma Ltd, Consilient Health Ltd, Day Lewis Medical Ltd, Focus Pharmaceuticals Ltd, Galvany Pharma, Gennisium Pharma SAS, Glenmark Pharmaceuticals Europe Ltd, Grindeks Kalceks, Hikma Pharmaceutical International Limited, Kent Pharmaceuticals Ltd, MSN Labs, Macure Pharma Aps, Martindale Pharma, Mercury Pharmaceuticals Limited, Morningside Pharmaceuticals Limited, Pfizer Limited, Ranbaxy (UK) Ltd, Rosemont Pharmaceuticals Ltd, STADA UK - Thornton & Ross, Sandoz, Stirling Anglian Pharmaceuticals, SyriMed, Viatris UK Healthcare Ltd, Wockhardt UK Limited, Zentiva Pharma UK Ltd, hameln pharma ltd Not published · Not published · active Focus Pharmaceuticals Ltd, STADA UK - Thornton & Ross Not published · Not published · active GlaxoSmithKline Not published · Not published · active Aventis Pharma Ltd t/a Sanofi, Day Lewis Medical Ltd, Techdow Pharma England Ltd, Venipharm LTD Not published · Not published · active Accord, Chiesi Limited, Martindale Pharma, Mercury Pharmaceuticals Limited, STADA UK - Thornton & Ross Not published · Not published · active Aventis Pharma Ltd t/a Sanofi, Day Lewis Medical Ltd, Martindale Pharma, STADA UK - Thornton & Ross Not published · Not published · active Selective Supplies Ltd Not published · Not published · active Accord, Aspire, CST Pharma Ltd, Chiesi Limited, Day Lewis Medical Ltd, GlaxoSmithKline, Glenmark Pharmaceuticals Europe Ltd, Kent Pharmaceuticals Ltd, STADA UK - Thornton & Ross, Sandoz, Selective Supplies Ltd, Wockhardt UK Limited Not published · Not published · active Colonis Pharma Ltd, Zentiva Pharma UK Ltd Not published · Not published · active Pfizer Limited Not published · Not published · active |
Contracts Epinephrine (Adrenaline) Pre-Filled Syringes £1,575,630 · signed 7 Apr 2025, 00:00 BST · active Tinzaparin Sodium Injections £848,290 · signed 7 Apr 2025, 00:00 BST · active Icatibant Solution for Injection £170,315 · signed 7 Apr 2025, 00:00 BST · active Treprostinil Injection £223,250 · signed 7 Apr 2025, 00:00 BST · active Direct Acting Oral Anticoagulants (DOACs) £446,140 · signed 7 Apr 2025, 00:00 BST · active All Other Cardiovascular & Respiratory Medicines £24,410,075 · signed 7 Apr 2025, 00:00 BST · active Nifedipine Modified-Release (M/R) Capsules and Tablets £13,855 · signed 7 Apr 2025, 00:00 BST · active Epoprostenol Powder and Solvent (pH 12) for Solution for Infusion Vials £10,789,555 · signed 7 Apr 2025, 00:00 BST · active Enoxaparin Sodium Injection £9,947,020 · signed 7 Apr 2025, 00:00 BST · active Isosorbide Mononitrate Modified-Release (M/R) Capsules and Tablets £53,405 · signed 7 Apr 2025, 00:00 BST · active Diltiazem Hydrochloride Modified-Release (M/R) Capsules and Tablets £81,720 · signed 7 Apr 2025, 00:00 BST · active Verapamil Hydrochloride Modified-Release (M/R) Capsules and Tablets £37,695 · signed 7 Apr 2025, 00:00 BST · active Branded and Branded Generic Inhalers £2,961,460 · signed 7 Apr 2025, 00:00 BST · active Iloprost Medicines £257,595 · signed 7 Apr 2025, 00:00 BST · active Dalteparin Injections £30,489,875 · signed 7 Apr 2025, 00:00 BST · active |
Bid statistics bids: 3 (lot 10) electronicBids: 3 (lot 10) foreignBidsFromEU: 0 (lot 10) foreignBidsFromNonEU: 3 (lot 10) smeBids: 0 (lot 10) bids: 12 (lot 12) electronicBids: 12 (lot 12) foreignBidsFromEU: 0 (lot 12) foreignBidsFromNonEU: 12 (lot 12) smeBids: 0 (lot 12) bids: 2 (lot 13) electronicBids: 2 (lot 13) foreignBidsFromEU: 0 (lot 13) foreignBidsFromNonEU: 2 (lot 13) smeBids: 0 (lot 13) bids: 1 (lot 14) electronicBids: 1 (lot 14) foreignBidsFromEU: 0 (lot 14) foreignBidsFromNonEU: 1 (lot 14) smeBids: 0 (lot 14) bids: 2 (lot 15) electronicBids: 2 (lot 15) foreignBidsFromEU: 0 (lot 15) foreignBidsFromNonEU: 2 (lot 15) smeBids: 0 (lot 15) bids: 6 (lot 16) electronicBids: 6 (lot 16) foreignBidsFromEU: 0 (lot 16) foreignBidsFromNonEU: 6 (lot 16) smeBids: 0 (lot 16) bids: 1 (lot 17) electronicBids: 1 (lot 17) foreignBidsFromEU: 0 (lot 17) foreignBidsFromNonEU: 1 (lot 17) smeBids: 0 (lot 17) bids: 11 (lot 18) electronicBids: 11 (lot 18) foreignBidsFromEU: 0 (lot 18) foreignBidsFromNonEU: 11 (lot 18) smeBids: 0 (lot 18) bids: 42 (lot 19) electronicBids: 42 (lot 19) foreignBidsFromEU: 0 (lot 19) foreignBidsFromNonEU: 42 (lot 19) smeBids: 0 (lot 19) bids: 2 (lot 2) electronicBids: 2 (lot 2) foreignBidsFromEU: 0 (lot 2) foreignBidsFromNonEU: 2 (lot 2) smeBids: 0 (lot 2) bids: 2 (lot 3) electronicBids: 2 (lot 3) foreignBidsFromEU: 0 (lot 3) foreignBidsFromNonEU: 2 (lot 3) smeBids: 0 (lot 3) bids: 4 (lot 5) electronicBids: 4 (lot 5) foreignBidsFromEU: 0 (lot 5) foreignBidsFromNonEU: 4 (lot 5) smeBids: 0 (lot 5) bids: 5 (lot 7) electronicBids: 5 (lot 7) foreignBidsFromEU: 0 (lot 7) foreignBidsFromNonEU: 5 (lot 7) smeBids: 0 (lot 7) bids: 4 (lot 8) electronicBids: 4 (lot 8) foreignBidsFromEU: 0 (lot 8) foreignBidsFromNonEU: 4 (lot 8) smeBids: 0 (lot 8) bids: 1 (lot 9) electronicBids: 1 (lot 9) foreignBidsFromEU: 0 (lot 9) foreignBidsFromNonEU: 1 (lot 9) smeBids: 0 (lot 9) |
Buyer and organisations in this procedure
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Contracting authority GB-FTS-115937Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published